← Back to headlines
REGENXBIO Expands Board with Appointment of Greg Ciongoli
Gene therapy developer REGENXBIO has strengthened its leadership team by appointing Greg Ciongoli to the board to oversee strategic growth and corporate governance initiatives.
25 Aug, 11:05 — 25 Aug, 11:05
Sources
Showing 1 of 1 sources
Related Stories
Meta Agrees to $16.7 Billion Settlement in Landmark U.S. Social Media Lawsuits
16m ago
Armenian Banking Group Acquires Key Georgian Financial Assets
29m ago
Dubai Set to Award Dh55 Billion in Contracts for Airport Expansion
34m ago
Analysts Preview Second-Quarter Earnings for HealthEquity and Burlington
37m ago